Erratum to: First-in-human phase I study of SOR-C13, a TRPV6 calcium channel inhibitor, in patients with advanced solid tumors
Crossref DOI link: https://doi.org/10.1007/s10637-017-0455-y
Published Online: 2017-04-07
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fu, S.
Hirte, H.
Welch, S.
Ilenchuk, T. T.
Lutes, T.
Rice, C.
Fields, N.
Nemet, A.
Dugourd, D.
Piha-Paul, S.
Subbiah, V.
Liu, L.
Gong, J.
Hong, D.
Stewart, J. M.
Text and Data Mining valid from 2017-04-07
Version of Record valid from 2017-04-07
Article History
First Online: 7 April 2017